Key result
Radical mastectomy and adriamycin treat poorly differentiated primary breast angiosarcoma in a 44-year-old woman.
Why the study?
Primary breast angiosarcoma is a rare and aggressive tumor with nonspecific clinical and radiographic features, making early recognition and multidisciplinary diagnosis essential.
Case Report (n=1)
No
Primary breast angiosarcoma is a rare and aggressive tumor that requires histopathological analysis and a multidisciplinary approach for accurate diagnosis and treatment.
Requires histopathologic confirmation and multidisciplinary input for rare breast angiosarcomas; leaves open standardized regimens for aggressive subtypes.
Background/Aim: Breast angiosarcoma is a rare tumour of vascular endothelium origin, accounting for less than 0.05% of all breast malignancies. The aim of this case report was to point out the importance of early recognition and a multidisciplinary approach in the diagnosis and treatment of this rare entity. Case report: A 44-year-old woman presented for a clinical examination due to a tumour in her right breast. After a mammographic examination, which verified a highly suspicious lobular change at the junction of the upper quadrant of the right breast with a diameter of 86 × 98 mm, a biopsy with a core needle was performed, followed by a radical mastectomy. Pathohistologically, a vascular mesenchymal tumor was verified. Using the immunohistochemical staining method, the tumor showed immunoreactivity to Vimentin, CD31, CD34, and Factor VIII, while AE1/AE3, EMA, estrogen, progesterone, and HER2 were negative, and the diagnosis of poorly differentiated primary angiosarcoma was made. Conclusion: Primary breast angiosarcoma represents a real diagnostic challenge. Due to the tumor's rarity and aggressiveness, a multidisciplinary approach to diagnosis and treatment is essential. Because of the nonspecific clinical and radiographic features of primary angiosarcoma, differential diagnoses encompass both benign and malignant breast conditions. Therefore, histopathological analysis is crucial for accurate diagnosis.
No takes yet. Share an insight, caveat, or question.
Živković et al. (2024) conducted a case report in Primary angiosarcoma of the breast (n=1). Radical mastectomy and adriamycin chemotherapy was evaluated. A 44-year-old woman was diagnosed with poorly differentiated primary breast angiosarcoma and treated with radical mastectomy followed by systemic chemotherapy with adriamycin.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: